Screening for hypertension in pregnancy.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Cardiovascular Health in Pregnancy

Background:

• Hypertension in pregnancy, including preeclampsia, is a significant concern for maternal and fetal health.
• Current screening methods for hypertensive disorders in pregnancy have limitations in predicting adverse outcomes.
• Identifying reliable predictors is crucial for timely intervention and improved pregnancy outcomes.

Purpose of the Study:

• To review the literature on screening for hypertension in pregnancy.
• To identify key factors associated with the development of preeclampsia.
• To determine the best predictors of poor pregnancy outcomes in hypertensive pregnancies.

Main Methods:

• Systematic literature review of studies on screening for hypertension in pregnancy.
• Analysis of blood pressure trends (early and mid-pregnancy) and proteinuria development.
• Evaluation of risk factors, including parity and pre-existing hypertension.

Main Results:

• No single factor guarantees protection against preeclampsia development.
• Elevated blood pressure in early pregnancy and a lack of decrease in mid-pregnancy are associated with preeclampsia risk.
• Proteinuria is a stronger predictor of poor pregnancy outcomes than blood pressure levels.

Conclusions:

• Proteinuria is the most significant predictor of adverse pregnancy outcomes in women with hypertension.
• Multiparas with severe chronic hypertension who develop preeclampsia face the highest risk.
• Enhanced monitoring for proteinuria is vital in managing hypertensive pregnancies.